Skip to main content
. 2021 Mar 12;8:648212. doi: 10.3389/fcvm.2021.648212

Figure 4.

Figure 4

The association between metformin and non-metformin and clinical outcomes in HbA1c ≥7% subgroup. Metformin was positively related to the all-cause mortality (P = 0.017) (A) but has no effect on cardiovascular death (P = 0.092) (B), all-cause hospitalizations (P = 0.671) (C), or hospitalization for heart failure (P = 0.304) (D).